Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

The world-renowned Israeli-Argentine pianist and conductor Daniel Barenboim revealed Thursday he is suffering from ...

Today’s Forbes Daily newsletter covers DOGE’s access to Treasury and Medicare data, America’s best banks, Google’s DEI shift, ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...

Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

In Parkinson’s disease, alpha-synuclein is abnormally folded, which causes it to clump up in dopamine-producing neurons and form a mass called a Lewy body. Lewy bodies destroy neurons, leading to ...